From: Late somatic sequelae after treatment of childhood cancer in Slovenia
Treatment | |||||||
---|---|---|---|---|---|---|---|
Primary diagnosis | S | RT | CHT | S_RT | S_CHT | RT_CHT | S_RT_CHT |
Leukemia | 0.6% | 1.1% | 27.0% | 0.6% | 0.0% | 70.1% | 0.6% |
NHL | 2.3% | 3.4% | 25.3% | 3.4% | 16.1% | 41.4% | 8.0% |
Neuroblastoma | 37.5% | 4.2% | 0.0% | 8.3% | 25.0% | 4.2% | 20.8% |
Other malignant neoplasms | 40.0% | 2.9% | 2.9% | 20.0% | 25.7% | 0.0% | 8.6% |
Rhabdomyosarcoma | 2.9% | 0.0% | 0.0% | 0.0% | 20.6% | 29.4% | 47.1% |
HD | 0.0% | 5.7% | 4.1% | 8.9% | 1.6% | 59.3% | 20.3% |
CNS | 31.9% | 3.5% | 0.0% | 35.4% | 2.1% | 2.8% | 24.3% |
Soft-tissue sarcomas | 24.6% | 0.0% | 0.0% | 10.8% | 50.8% | 1.5% | 12.3% |
Malignant bone tumors | 3.9% | 0.0% | 0.0% | 7.8% | 60.8% | 13.7% | 13.7% |
Other carcinomas | 60.0% | 2.9% | 0.0% | 18.6% | 5.7% | 4.3% | 8.6% |
Renal tumors | 2.2% | 0.0% | 0.0% | 11.1% | 40.0% | 0.0% | 46.7% |